About Cambrex
Cambrex is a company based in East Rutherford (United States) founded in 1981 was acquired by Permira in August 2019.. The company has 46 employees as of December 31, 2022. Cambrex has completed 7 acquisitions, including Avista Pharma, Biocatalysis and Halo Pharma. Cambrex offers products and services including Custom API Development, Analytical Testing, and Formulation Development. Cambrex operates in a competitive market with competitors including Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others.
- Headquarter East Rutherford, United States
- Employees 46 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cambrex Corporation
-
Annual Revenue
$532.09 M0as on Dec 31, 2018
-
Net Profit
$92.42 M-10as on Dec 31, 2018
-
EBITDA
$101.5 M-30as on Dec 31, 2018
-
Latest Funding Round
- Investors
-
Employee Count
46
as on Dec 31, 2022
-
Investments & Acquisitions
Avista Pharma
& 6 more
-
Acquired by
Permira
(Aug 07, 2019)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cambrex
Cambrex offers a comprehensive portfolio of products and services, including Custom API Development, Analytical Testing, and Formulation Development. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Offers custom development and manufacturing of pharmaceutical APIs for clinical trials.
Provides comprehensive analytical testing for drug stability and impurity identification.
Supports early-phase formulation and clinical trial manufacturing processes.
Unlock access to complete
Senior Team
24 people
Software Development Team
18 people
Leadership Team
16 people
Human Resources and Administration
12 people
Finance and Accounting
10 people
Product Management Team
8 people
Principal Team
7 people
Sales and Marketing
7 people
Unlock access to complete
Funding Insights of Cambrex
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cambrex
Cambrex has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Permira. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are made in technology, consumer, healthcare, and service sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cambrex
Cambrex has strategically engaged in corporate development activities, having acquired 7 companies. Notable acquisitions include Avista Pharma, Biocatalysis and Halo Pharma. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Drug development, manufacturing, and testing services are provided to clients.
|
2015 | ||||
|
Drug discovery and development service provider
|
2014 | ||||
|
Stability storage services for pharmaceuticals and medical devices are provided.
|
2012 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Cambrex
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cambrex Comparisons
Competitors of Cambrex
Cambrex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Laurus Labs, Symbiotec, Provepharm Life Solutions, Beijing Biostar Technologies and SeQuent, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Pharmaceutical and biotechnology company
|
|
| domain | founded_year | HQ Location |
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
|
|
| domain | founded_year | HQ Location |
APIs and drug products are developed and valorized in pharmaceuticals.
|
|
| domain | founded_year | HQ Location |
APIs, intermediates, and biochemical reagents are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
APIs are developed and manufactured for therapeutic areas.
|
|
| domain | founded_year | HQ Location |
Contract development, manufacturing, and analytical services for APIs are offered.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cambrex
Frequently Asked Questions about Cambrex
When was Cambrex founded?
Cambrex was founded in 1981.
Where is Cambrex located?
Cambrex is headquartered in East Rutherford, United States. It is registered at East Rutherford, New Jersey, United States.
How many employees does Cambrex have?
As of Dec 31, 2022, the latest employee count at Cambrex is 46.
What is the annual revenue of Cambrex?
Annual revenue of Cambrex is $532.09M as on Dec 31, 2018.
What does Cambrex do?
Cambrex Corporation provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. They offer APIs, advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Their custom development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products. Cambrex also develops processes to manufacture drug substances for clients use in toxicology studies, clinical studies and commercial supply. Their range of services include route selection, process and analytical development, process optimization and scale-up, safety assessments and product formulation.
Who are the top competitors of Cambrex?
Cambrex's top competitors include Laurus Labs, Symbiotec and NGL Fine Chem.
What products or services does Cambrex offer?
Cambrex offers Custom API Development, Analytical Testing, and Formulation Development.
How many acquisitions has Cambrex made?
Cambrex has made 7 acquisitions, including Avista Pharma, Biocatalysis, and Halo Pharma.
Who are Cambrex's investors?
Cambrex has 1 investor. Key investors include Permira.